Mallinckrodt Pharmaceuticals Ireland Ltd

FDA Regulatory Profile

Mallinckrodt Pharmaceuticals Ireland Ltd appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (Z-0567-2022, Class II) was initiated on December 10, 2021.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-0567-2022Class IITHERAKOS CELLEX Photopheresis Procedural Kit, CLXUSADecember 10, 2021